Advanced Enzyme Technologies Ltd Reports 23% Revenue Growth in H1 FY26

Advanced Enzyme Technologies Ltd, a leading specialty biotech company, has announced its unaudited financial results for the second quarter and half year ended September 2025. The company's revenue from operations has grown by 23% on a y-o-y basis, reaching INR 3,704 Mn. The EBITDA margin stands at 31%, PBT margin at 31%, and PAT margin at 23%. The Human Nutrition segment delivered a strong outperformance of 21%, reaching INR 24,434 Mn. The Animal Nutrition segment also demonstrated robust growth, increasing by 28% to INR 452 Mn. The Bio-Processing segment grew by 17%, contributing INR 491 Mn. The Specialized Manufacturing segment grew by 42%, reaching INR 327 Mn. The company's profit after tax stands at INR 852 Mn during H1 FY26.